Learn More
Medchemexpress LLC Selumetinib (sulfate) | 943332-08-9 | 99.58% | C17H17BrClFN4O7S | 100 MG

Supplier: Medchemexpress LLC HY50706A100MG
Selumetinib (AZD6244) sulfate is a selective, non-ATP-competitive oral MEK1/2 inhibitor with an IC50 of 14 nM for MEK1. It inhibits ERK1/2 phosphorylation and can penetrate the blood-brain barrier.
- Selective, non-ATP-competitive oral MEK1/2 inhibitor
- Potency: Exhibits an IC50 of 14 nM for MEK1
- Inhibits ERK1/2 phosphorylation
- Capable of penetrating the blood-brain barrier
- Causes time- and dose-dependent reduction in DNA synthesis and cell viability
- Induces growth arrest and apoptosis
- Demonstrates anti-proliferative effects through G0/G1 arrest
- Leads to growth inhibition in various cell lines with B-Raf and Ras mutations
- Decreases growth rate of xenografts
- Induces tumor regressions
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.